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To better evaluate patient contribution in antibiotic use, we questioned 5379 subjects from 9 countries.
Antibiotics are perceived as strong, efficient drugs, but they are believed to undermine immunity. Interviewees
believe that most respiratory infections, except the common cold, require antibiotic therapy, and 11% of them
had to exaggerate their symptoms to get an antibiotic prescription from their physician. About 1 patient in
4 saved part of the antibiotic course for future use. Sixty-nine percent of the patients claimed to have taken
the course until the end (United Kingdom, 90%; Thailand, 53%), and 75% claimed that they actually took all
the daily doses. In all countries, it was possible to get antibiotics from a pharmacist without a medical
prescription. This study shows that patients exert pressure on their doctors to get antibiotics and should allow
a design for precise educational action aimed at the public for better control of antibiotic use in the community.
There is little doubt that the indiscriminate use of anti-
biotics has contributed to the emergence of bacterial
resistance, both in hospitals and community settings
[1]. The major force driving changes in the prevalence
of resistance in the community seems to be the volume
of drug use, and different epidemiological models have
been proposed to describe the phenomenon [2, 3]. A
more comprehensive strategy for better antibiotic use
is essential for preserving, as far as possible, the con-
siderable benefit of antibiotics. In particular, there is a
clear need to improve the scientific understanding of
the factors associated with antibiotic use. So far, most
of the efforts for controlling the use of antibacterial
agents have been directed toward the prescribers: guide-
lines, national and international antibiotic policies, and
educational programs. However, little is known about
the magnitude of patient contribution in antibiotic use,
so no sound strategy has been developed for educating
the public.
In this study, we have examined some patients’ at-
titudes toward antibiotics. We questioned them directly,
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because it has been recognized that at least in the do-
main of adherence to treatment, physicians may be not
good predictors of their patients’ views [4, 5]. Through
telephone interviews, we tried to learn more about their
perceptions of common respiratory tract infections,
their requirements for antibiotic use, and their adher-
ence to the treatment as prescribed. A first limited Pan-
European study suggested that patients’ attitudes varied
according to their country of residence [6], so the pre-
sent survey has been extended to Asia, Africa, and
Colombia.
SUBJECTS AND METHODS
Subjects. All subjects were interviewed for 20
minutes by telephone. During the last 12 months, all
those questioned had either taken a course of antibiotics
or had given one to their child for an ambulatory res-
piratory tract infection. For ascertaining the diagnosis
of respiratory infection, the following words were used
in the questions: flu, cold, earache, sore throat, thick
catarrh, bad cough. Approximately 600 interviewees
were randomly selected from each of the following 9
countries: United Kingdom, France, Belgium, Italy,
Spain, Turkey, Thailand, Morocco, and Colombia. Ran-
domization of interviewees was performed by a medical
market research company (Millward Brown Market Re-
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Speed recovery (87) Undermine natural immunity (59)
Provide effective cure (80) Had side effects during the last
course (27)
Strong drugs (74) Unpredictable (18)
A savior (51) Mysterious (18)
Dependable (45) Aggressive (19)
Gentle (16) Frightening (11)
search, Tachbrook Park, Warwick, United Kingdom). The se-
lection was done through random digit dialing, where numbers
that conform to the local telephone number structure are gen-
erated by computer in a totally random fashion. The targets
are then contacted and selected for further interview via a
screening process to see if they fit the profile for the research.
To prevent any bias, we excluded potential interviewees if they
or a close member of the family were involved in any of the
following occupations: market research, marketing, advertising,
journalism, newspaper production, pharmaceutical industry,
health services. In each country, approximately 200 interviewees
were drawn from each of 3 demographic groups: working
adults, aged 18–54 years; adults over 55 years; and mothers of
children aged 0–12 years.
Questionnaires. Identical questionnaires, made up of 21
multiple choice questions, were used in the 9 countries. Ques-
tions determined the socioeconomic status of the interviewee
as well as the seriousness of the respiratory tract infection for
which the antibiotic was prescribed and how the patient or
parent viewed the need for medical advice and drug therapy.
Interviewees were also questioned about their belief in anti-
biotic therapy, the way the drugs work and their effects, and
their perception of doctors. Interviewees were also asked about
their adherence to their most recent course of antibiotics in
terms of taking the required number of daily doses and the full
duration of the course.
Data analysis. There was no intention to try to establish
any statistically significant difference across the 9 countries. It
was initially hoped that any difference in attitudes of patients
in the different countries would become apparent. To assist in
the interpretation of the data, we analyzed patient responses
by using correspondence analysis [7].
RESULTS
A total of 5379 subjects (initial target: 5400) were interviewed,
including 1798 working adults, 1766 older adults, and 1815
mothers (no overlaps between the 3 groups). The last experi-
enced respiratory infection was perceived as potentially severe
by the majority of the interviewees, with large variations ac-
cording to the group and the country. Thirty-seven percent of
adults felt sorry for themselves (“could not go to work, could
not sleep, could not eat, needed to have somebody with me in
the house, felt emotionally down/gloomy”) (Europe, 35%; Tur-
key, 66%), and 62% of them worried it could turn into some-
thing worse (mothers, 82%; Colombian adults, 82%; Colom-
bian mothers, 97%). Sixty-eight percent of the interviewees
wanted to see a doctor for this condition (mothers, 89%; Italy,
91%; Colombian mothers, 94%). However, 34% of the mothers
(43% in Colombia) thought they were a better judge than their
doctor. Twenty percent of the interviewees tried traditional
remedies first (older people, 30%), and 32% got something
directly from the pharmacist. This included antibiotics in the
9 countries of the survey.
The majority of those questioned believed (but did not nec-
essarily expect) that for most respiratory tract infections an-
tibiotics should be prescribed: sore throat, 72%; fever, 67%;
earache, 65% (in the United Kingdom, 90%); thick catarrh,
64%; bad cough, 65%; and flu, 64%; but common cold, only
37%. Eleven percent of those questioned admitted that they
had to exaggerate symptoms to get antibiotics from their phy-
sician. Overall, antibiotics have a positive public image, even
though some negative perceptions were also mentioned (table
1). The fear that antibiotics would destroy red blood cells was
expressed in Colombia, but not elsewhere (Colombian mothers,
38%). This opinion might be connected with the fact that
chloramphenicol is available and widely used in Colombia.
Twenty-seven percent of interviewees experienced side effects
during the last course of antibiotics they received. Older pa-
tients complained most of dizziness and headaches, whereas
diarrhea and rashes were more common in children.
Forty-one percent of mothers had concerns about their child
taking antibiotics, with wide differences from country to coun-
try: more concerns in Colombia (75%) and Turkey (64%), less
in Thailand (28%) and Spain (14%). A large majority of in-
terviewees believed that doses should be taken at exact intervals
as prescribed, including during the night. Almost a quarter of
the patients (24%) or mothers saved part of the antibiotic
course for future use. Noncompliance behavior was commonly
recorded. Only 3 of 4 patients admitted that they took all daily
doses (mothers, 78%; older adults, 79%; working adults, 67%).
The percentage of patients who claimed to finish the antibiotic
course varied from 53% in Thailand to 90% in the United
Kingdom (table 2). The reasons for stopping the course pre-
maturely were mostly because the patients felt better (87%).
Memory loss, side effects, and bad taste in the mouth were
quoted in 5% of cases or less.
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Table 2. Percentage of patients who claimed to finish the
course of antibiotics, and those who saved part of the course
for future use.
Country
Percentage of patients who
Claimed to
finish the course
Saved part of the
course for future use











This survey suggests that patients represent a significant source
of antibiotic misuse in the community. Most respiratory tract
infections were perceived as potentially severe especially in Mo-
rocco, Thailand, Turkey, and Colombia, and hence the pre-
scription of an efficient therapy was expected. Some patients
had to exaggerate their symptoms to get the prescription. A
majority of patients were willing to take antibiotics for con-
ditions likely to have a viral origin, such as flu, sore throat,
cough, or earache. Data suggest that patients can exert pressures
on doctors for antibiotic prescriptions for common respiratory
tract infections. Keeping leftover medication for future use was
another source of misuse, because these antibiotics are kept in
uncontrolled conditions and potentially used later without a
medical prescription. It was possible to get antibiotics directly
from the pharmacist without prescription in all 9 countries of
the survey, even where this practice is illegal. This gray area of
pharmaceutical practice deserves further investigation to know
the relative importance of over-the-counter sales. Recently, in
Kathmandu, Nepal, it was documented that all 100 pharma-
ceutical retailers contacted by a mock patient engaged in di-
agnostic and therapeutic behavior beyond their scope and train-
ing or legal mandate. Unnecessary antimicrobial agents were
dispensed by 97% and 38% of retailers for diarrhea and dysuria,
respectively [8].
Recent studies in European children, also by means of stan-
dardized telephone interviews after antibiotic courses for com-
mon respiratory infections, gave similar figures on nonadher-
ence attitudes as those presented in table 2: 55.7% in Spain [9]
and 69.5% in Germany [10]. However precise evaluation of
nonadherence attitudes toward treatment is problematic. Phy-
sicians are not good predictors of their patients’ compliance
[3, 4], and it is very likely that self-reporting substantially un-
derestimates noncompliance. A recent report on compliance
with doxycycline therapy for Chlamydia-associated syndromes
indicated that 90% of the patients reported taking their med-
ication as directed, but only 16% achieved this level of com-
pliance according to the data obtained with medication event
monitoring system caps [11]. Noncompliance may have an
impact on antibiotic resistance in the community, as illustrated
in multiple drug–resistant tuberculosis [12]. With the resistance
perspective, we have distinguished 2 types of misbehavior. Type
A consists in shorter than prescribed courses. By reducing the
antibiotic pressure, provided that the daily doses are otherwise
respected, one may see a theoretical advantage vis-a`-vis the
selection of resistance during therapy. Type B noncompliance
reduces the number of daily doses, a behavior commonly com-
bined with type A. Missing 1 dose leads necessarily to lower
serum/tissue area under the curve and shorter time of antibiotic
concentrations over the MIC during the corresponding nyc-
tohemeral period. Animal studies and at least 1 clinical study
indicate that such underdosing may promote the selection of
resistance during therapy [13]. If so, type B noncompliance
could contribute to the resistance burden in the community.
Patients’ attitudes varied according to the country. Spain and
Thailand were characterized by low compliance and low per-
centage of mothers having concerns about their child taking
antibiotics, implying that antibiotics are considered as trivial
drugs. The British appeared as the most disciplined patients,
with high self-reported compliance, drugs taken at exact in-
tervals, and high respect for the physicians, a trait also shared
in Belgium and France. Much more emotional attitudes were
recorded in Turkey and Colombia: antibiotics are “strong,” they
undermine immunity, part of a course can be saved for future
use, great concerns regarding the children with respiratory in-
fection are expressed, the demand for medical support is high
even though many mothers think they are better judges than
their doctors. The reasons for these differences are probably
multiple, including access to medical care facilities, health in-
surance system as illustrated in a study conducted in rural
China [14], education, and even cultural background.
We conclude this study by highlighting the need to educate
patients regarding antibiotic use and the consequences of mis-
use: what diseases actually require antibiotics, why full daily
doses must be respected, absence of significant alterations of
immunity associated with antibiotic therapy, danger of keeping
part of a course for future uncontrolled use, and need of a
prescription for getting antibiotics from the pharmacist could
be some of the issues to be discussed with the patients.
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